Establishing mass-production capacity and preparing for overseas expansion of plant-based wastewater treatment agents
First written in FY2018. 3 of 5 entries say "Materialised", first in FY2021. Latest entry: FY2023.
Dexerials moved to the "Worse" side of this theme in 2021.
0 other companies' latest entry also says "Materialised".
- FY2023MaterialisedAnnual report
「Water purification agent-related assets 1」
The company also recognized an impairment loss of ¥1 million on plant-based water purification agent-related assets for the fiscal year. - FY2022MaterialisedAnnual report
「Water purification agent-related assets ¥2 million」
The company also recognized an impairment loss of ¥2 million on plant-based water purification agent-related assets for the fiscal year. - FY2021MaterialisedAnnual report
「Water purification agent 268 Because the originally anticipated revenue can no longer be expected and the possibility of sale is also low, an impairment loss was recorded because no recoverable amount is expected.」
An impairment loss of ¥268 million was recorded for the plant-based wastewater treatment agent because the anticipated revenue could no longer be expected. - FY2019RestatedAnnual report
「In the environment and life sciences fields, we offer wastewater treatment agents containing plant-derived ingredients and antireflection films for medical eye shields.」
The Company continued to offer plant-based wastewater treatment agents as products in the environment and life sciences fields. - FY2018First statedAnnual report
「For the fiscal year ending March 2019, we will establish mass-production capabilities and prepare for overseas expansion with a view to broadening our customer base.」
The Company planned to establish mass-production capabilities and prepare for overseas expansion of a plant-based, low-environmental-impact industrial wastewater treatment agent.